CX Institutional’s Amphastar Pharmaceuticals AMPH Stock Holding History

CX Institutional’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$25K	Sell	1,259 -1,714	-58%	-$34.6K	﹤0.01%	1118
2026 Q1	$58K	Sell	2,973 -61,150	-95%	-$1.5M	﹤0.01%	948
2025 Q4	$1.72M	Buy	64,123 +807	+1%	+$20.8K	0.05%	224
2025 Q3	$1.69M	Sell	63,316 -199,967	-76%	-$5.16M	0.05%	226
2025 Q2	$6.04M	Buy	263,283 +181,136	+221%	+$4.49M	0.21%	117
2025 Q1	$2.38M	Buy	+82,147	New	+$2.62M	0.09%	180

Other funds holding AMPH

LAM Group Lake Oswego, Oregon $201M AUM 22.35% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Assenagon Asset Management

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Significant Wealth Partners Cary, Illinois $92.4M AUM 9.22% 1-Year Est. Return

1620 Investment Advisors Plymouth, Massachusetts $161M AUM 30.15% 1-Year Est. Return

MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return